Press coverage about Everyday Health (NYSE:EVDY) has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Everyday Health earned a news sentiment score of 0.02 on Accern’s scale. Accern also assigned headlines about the technology company an impact score of 45.1057883314166 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Shares of Everyday Health (EVDY) opened at $10.50 on Monday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.61 and a quick ratio of 1.61. Everyday Health has a 52 week low of $3.71 and a 52 week high of $10.50.

ILLEGAL ACTIVITY NOTICE: “Everyday Health (EVDY) Receives News Sentiment Rating of 0.02” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.watchlistnews.com/everyday-health-evdy-receives-news-sentiment-rating-of-0-02/1729016.html.

About Everyday Health

Everyday Health, Inc, formerly Waterfront Media Inc, operates a digital marketing and communications platform for healthcare marketers that want to engage with consumers and healthcare professionals. The Company’s platform combines content from brands, data and analytics. The Company’s segment is providing digital health marketing and communications solutions.

Insider Buying and Selling by Quarter for Everyday Health (NYSE:EVDY)

Receive News & Ratings for Everyday Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everyday Health Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.